Nuclei-free cells prove utility in delivering therapeutics to diseased tissues
Mathematical model may help improve treatments and clinical trials of patients with COVID-19 and other illnesses
14 January 2022Young Alzheimer’s patients dealt a blow by Medicare’s refusal to cover drug
14 January 2022Nuclei-free cells prove utility in delivering therapeutics to diseased tissues
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health report successfully removing the nucleus out of a type of ubiquitous cell, known as enucleation, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.
